A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance

Stephen C. Pflugfelder, Roger Vogel, Edward J. Holland et al.|American Journal of Ophthalmology|2004

Cited by 231